Lilly sales dip 11% as diabetes drugs feel payer pressure
October 24 2012
Price increases and belt-tightening helped prop up Eli Lilly's third quarter, but loss of formulary positioning on two key products ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.